U R M Bohr

Summary

Affiliation: Otto-von-Guericke University
Country: Germany

Publications

  1. pmc Identification of enterohepatic Helicobacter species in patients suffering from inflammatory bowel disease
    Ulrich R M Bohr
    Department of Gastroenterology, Hepatology and Infectious Diseases, Otto von Guericke University Magdeburg, Leipziger Strasse 44, D 39120 Magdeburg, Germany
    J Clin Microbiol 42:2766-8. 2004
  2. pmc Prevalence and spread of enterohepatic Helicobacter species in mice reared in a specific-pathogen-free animal facility
    U R M Bohr
    Department of Gastroenterology, Hepatology and Infectious Diseases, Otto von Guericke University Magdeburg, Leipziger Strasse 44, D 39120 Magdeburg, Germany
    J Clin Microbiol 44:738-42. 2006
  3. ncbi request reprint Low prevalence of Helicobacteraceae in gall-stone disease and gall-bladder carcinoma in the German population
    U R M Bohr
    Department of Gastroenterology, Hepatology and Infectious Diseases, Otto von Guericke University, Magdeburg, Germany
    Clin Microbiol Infect 13:525-31. 2007
  4. doi request reprint [Rare neuroendocrine carcinoma of the gall bladder. Coincidental occurrence of an endometrioid ovarian adenocarcinoma]
    M Petersen
    Klinik fUr Allgemein, Viszeral und Gefässchirurgie, Universitatsklinikum, Magdeburg, Germany
    Dtsch Med Wochenschr 134:19-22. 2009
  5. ncbi request reprint A group-specific PCR assay for the detection of Helicobacteraceae in human gut
    Ulrich R M Bohr
    Department of Gastroenterology, Hepatology and Infectious Diseases, Otto von Guericke University, Magdeburg, Germany
    Helicobacter 7:378-83. 2002
  6. ncbi request reprint Detection of a putative novel Wolinella species in patients with squamous cell carcinoma of the esophagus
    Ulrich R M Bohr
    Department of Gastroenterology, Hepatology and Infectious Diseases, Otto von Guericke University, Magdeburg, Germany
    Helicobacter 8:608-12. 2003
  7. ncbi request reprint Extragastric manifestations of Helicobacter pylori infection -- other Helicobacters
    Ulrich R M Bohr
    Department of Gastroenterology, Hepatology and Infectious Diseases, Otto von Guericke University, Magdeburg, Germany
    Helicobacter 12:45-53. 2007
  8. ncbi request reprint Inflammatory bowel diseases: multiple benefits from therapy with dipeptidyl- and alanyl-aminopeptidase inhibitors
    Ute Bank
    IMTM GmbH, Department ImmunoPharm, Magdeburg, Germany
    Front Biosci 13:3699-713. 2008

Collaborators

Detail Information

Publications8

  1. pmc Identification of enterohepatic Helicobacter species in patients suffering from inflammatory bowel disease
    Ulrich R M Bohr
    Department of Gastroenterology, Hepatology and Infectious Diseases, Otto von Guericke University Magdeburg, Leipziger Strasse 44, D 39120 Magdeburg, Germany
    J Clin Microbiol 42:2766-8. 2004
    ..Enterohepatic Helicobacter species were detected in 12% (3 of 25) of the patients with Crohn's disease, in 17% (3 of 18) of the ulcerative colitis samples, and in 4% (1 of 23) of the controls...
  2. pmc Prevalence and spread of enterohepatic Helicobacter species in mice reared in a specific-pathogen-free animal facility
    U R M Bohr
    Department of Gastroenterology, Hepatology and Infectious Diseases, Otto von Guericke University Magdeburg, Leipziger Strasse 44, D 39120 Magdeburg, Germany
    J Clin Microbiol 44:738-42. 2006
    ..Moreover, there is a high prevalence of rather uncommon Helicobacter species that may be a consequence of the current routine procedures used for health screening of SPF mice...
  3. ncbi request reprint Low prevalence of Helicobacteraceae in gall-stone disease and gall-bladder carcinoma in the German population
    U R M Bohr
    Department of Gastroenterology, Hepatology and Infectious Diseases, Otto von Guericke University, Magdeburg, Germany
    Clin Microbiol Infect 13:525-31. 2007
    ..The low prevalence could be a possible explanation for a relatively low incidence of GBC in the German population, despite the fact that GSD, the major risk-factor for GBC, is highly prevalent...
  4. doi request reprint [Rare neuroendocrine carcinoma of the gall bladder. Coincidental occurrence of an endometrioid ovarian adenocarcinoma]
    M Petersen
    Klinik fUr Allgemein, Viszeral und Gefässchirurgie, Universitatsklinikum, Magdeburg, Germany
    Dtsch Med Wochenschr 134:19-22. 2009
    ..The histological investigation of a surgical specimen (after cholecystectomy) from a 73-year-old woman revealed a poorly differentiated carcinoma with glandular structures and a lymph node metastasis...
  5. ncbi request reprint A group-specific PCR assay for the detection of Helicobacteraceae in human gut
    Ulrich R M Bohr
    Department of Gastroenterology, Hepatology and Infectious Diseases, Otto von Guericke University, Magdeburg, Germany
    Helicobacter 7:378-83. 2002
    ..Enterohepatic Helicobacter species are emerging pathogens, which are increasingly isolated from humans with enteric diseases. Nevertheless, current methods to detect Helicobacteraceae in the human gut have significant limitations...
  6. ncbi request reprint Detection of a putative novel Wolinella species in patients with squamous cell carcinoma of the esophagus
    Ulrich R M Bohr
    Department of Gastroenterology, Hepatology and Infectious Diseases, Otto von Guericke University, Magdeburg, Germany
    Helicobacter 8:608-12. 2003
    ..Bacteria belonging to the family Helicobacteraceae are candidates for involvement in the initiation of the esophagitis. We investigated patients with esophageal carcinoma for the occurrence of Helicobacter-related species...
  7. ncbi request reprint Extragastric manifestations of Helicobacter pylori infection -- other Helicobacters
    Ulrich R M Bohr
    Department of Gastroenterology, Hepatology and Infectious Diseases, Otto von Guericke University, Magdeburg, Germany
    Helicobacter 12:45-53. 2007
    ..There is also an increasing evidence for a possible association of H. pylori with cardiovascular disease...
  8. ncbi request reprint Inflammatory bowel diseases: multiple benefits from therapy with dipeptidyl- and alanyl-aminopeptidase inhibitors
    Ute Bank
    IMTM GmbH, Department ImmunoPharm, Magdeburg, Germany
    Front Biosci 13:3699-713. 2008
    ....